Literature DB >> 11679955

Transforming growth factor beta and the liver.

D M Bissell1, D Roulot, J George.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679955     DOI: 10.1053/jhep.2001.28457

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  90 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.

Authors:  Xiao-Ling Wu; Wei-Zheng Zeng; Pi-Long Wang; Chun-Tao Lei; Ming-De Jiang; Xiao-Bin Chen; Yong Zhang; Hui Xu; Zhao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver.

Authors:  Ming-Ling Chang; Jeng-Chang Chen; Claudio R Alonso; Alberto R Kornblihtt; D Montgomery Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

Review 4.  Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

Authors:  Y Inagaki; I Okazaki
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.

Authors:  Maria Eduarda Rocha de França; Sura Wanessa Santos Rocha; Wilma Helena Oliveira; Laise Aline Santos; Anne Gabrielle Vasconcelos de Oliveira; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; Gabriel Barros Rodrigues; Deniele Bezerra Lós; Christina Alves Peixoto
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

6.  Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression.

Authors:  Sang Hwa Lee; Sung-Im Do; Hyun-Soo Kim
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

7.  Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.

Authors:  Shi-Ling Song; Zuo-Jiong Gong; Quan-Rong Zhang; Tuan-Xin Huang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

8.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Authors:  Tetsuya Shimizu; Shigeki Yokomuro; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Yasuo Arima; Nobuhiko Taniai; Yasuhiro Mamada; Hiroshi Yoshida; Koho Akimaru; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

10.  Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.

Authors:  Lian-Sheng Wang; Ying-Wei Chen; Ding-Guo Li; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.